Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome
- PMID: 1384511
- DOI: 10.1002/art.1780351013
Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome
Abstract
Objective: To evaluate correlations between changes in anti-U1 RNA antibody levels and disease activity in 9 patients with systemic lupus erythematosus (SLE) overlap syndrome who were prospectively followed up for at least 3 years.
Methods: Anti-U1 RNA antibody levels were measured quantitatively, using a nitrocellulose filter binding assay. Disease activity was measured with a validated SLE activity index.
Results: All 9 major disease exacerbations were associated with peaks in anti-U1 RNA antibody level.
Conclusion: These results seem to indicate that measuring anti-U1 RNA antibody levels can be useful for monitoring disease activity.
Similar articles
-
Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.Rev Rhum Engl Ed. 1998 Jun;65(6):378-86. Rev Rhum Engl Ed. 1998. PMID: 9670329
-
The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients.J Immunol. 1999 Sep 15;163(6):3304-12. J Immunol. 1999. PMID: 10477600
-
Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.Lupus. 2013 Nov;22(13):1371-81. doi: 10.1177/0961203313508444. Lupus. 2013. PMID: 24158973 Free PMC article.
-
The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity.Isr Med Assoc J. 2002 Sep;4(9):706-12. Isr Med Assoc J. 2002. PMID: 12440236 Review.
-
The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.Rheumatol Int. 2018 Jul;38(7):1169-1178. doi: 10.1007/s00296-018-4059-4. Epub 2018 May 23. Rheumatol Int. 2018. PMID: 29796907 Review.
Cited by
-
Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodies.Clin Rheumatol. 2005 Sep;24(5):453-9. doi: 10.1007/s10067-004-1054-9. Epub 2004 Dec 10. Clin Rheumatol. 2005. PMID: 16328603
-
T cell vaccination therapy in an induced model of anti-RNP autoimmune glomerulonephritis.Clin Immunol. 2010 Nov;137(2):281-7. doi: 10.1016/j.clim.2010.07.013. Epub 2010 Aug 24. Clin Immunol. 2010. PMID: 20797908 Free PMC article.
-
Activation of interferon regulatory factor-3 via toll-like receptor 3 and immunomodulatory functions detected in A549 lung epithelial cells exposed to misplaced U1-snRNA.Nucleic Acids Res. 2009 Aug;37(15):5041-56. doi: 10.1093/nar/gkp525. Epub 2009 Jun 18. Nucleic Acids Res. 2009. PMID: 19541850 Free PMC article.
-
Clinical relevance of autoantibodies in systemic rheumatic diseases.Mol Biol Rep. 1996;23(3-4):133-45. doi: 10.1007/BF00351161. Mol Biol Rep. 1996. PMID: 9112221 Review.
-
Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA.Clin Exp Immunol. 1995 Jan;99(1):29-36. doi: 10.1111/j.1365-2249.1995.tb03468.x. Clin Exp Immunol. 1995. PMID: 7529149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
